PCL, Inc. (KOSDAQ:241820)
South Korea · Delayed Price · Currency is KRW 302.00
-5.00 (-1.63%)
Mar 21, 2025, 5:32 PM KST
PCL, Inc. Market Cap
PCL, Inc. has a market cap or net worth of 17.87 billion as of September 19, 2025. Its market cap has decreased by -80.21% in one year.
Market Cap
17.87B
Enterprise Value
23.99B
Revenue
4.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
302.00
Market Cap Chart
Since February 23, 2017, PCL, Inc.'s market cap has decreased from 81.72B to 17.87B, a decrease of -78.13%. That is a compound annual growth rate of -17.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 21, 2025 | 17.87B | -45.49% |
| Dec 30, 2024 | 32.78B | -82.25% |
| Dec 28, 2023 | 184.73B | 5.32% |
| Dec 29, 2022 | 175.40B | -51.95% |
| Dec 30, 2021 | 365.08B | -0.90% |
| Dec 30, 2020 | 368.38B | 379.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| SK Biopharmaceuticals | 8,888.55B |
| Yuhan | 8,872.07B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |